MDCL

Medicine Man Technologies Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 10/20/2016
Contact Info
  • 4880 Havana Street
  • Suite 102 South
  • Denver, CO 80239

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001622879
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8742 - Management consulting services
Incorporated In: NV, USA
Year of Inc. 2014
Employees 5 a/o Apr 28, 2016
Company Officers/Contacts
Andrew Johns Williams CEO, Other
Brett Edward Roper COO, Other
Paul Daniel Dickman CFO
Company Directors
Brett Edward Roper Chairman
James Sylvester Toreson
Andrew Johns Williams
Service Providers
Accounting/Auditing Firm
BF Borgers CPA PC
5400 West Cedar Avenue
Lakewood, CO, 80226
United States

Legal Counsel
Andrew I Telsey, Esq.
12835 E. Arapahoe Road, Tower One,
Suite 803
Englewood, CO, 80112-55427
United States

Investor Relations Firm
Not Available
MDCL Security Details
Share Structure
Market Value1 $28,662,700 a/o Dec 02, 2016
Authorized Shares 90,000,000 a/o Apr 19, 2016
Outstanding Shares 10,092,500 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 3,652,012 a/o Nov 04, 2016
Par Value 0.001
Transfer Agent(s)
Globex Transfer, LLC
Shareholders
Shareholders of Record 500 a/o Nov 01, 2016
Short Selling Data
Short Interest 42,167 (115.21%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security